In an expansion of his written three-part series for PharmTech, Jason Bryant of ArisGlobal explains the interplay between ...

The year 2025 was defined by escalating global trade tensions that fundamentally reshaped the pharmaceutical supply chain, ...

Multiple departments, including engineering and quality assurance, are responsible for evaluating GMP equipment and ...

AstraZeneca's MFN pricing agreement with the US government reflects broader efforts to reduce drug prices and enhance ...

Mike Stenberg, LGM Pharma, outlines how GLP-1s, AI, and 505(b)(2) delivery shifts are driving pharmaceutical innovation.

FDA has taken steps to embrace AI in 2025, announcing in December that it will be providing agency staff with agentic AI ...

The pharmaceutical industry requires rapid training to address workforce shortages for new US manufacturing facilities, ...

André Cerbe, CEO of Schlafender Hase, spoke with Pharmaceutical Technology® about the disruptions the pharma industry faced ...

Frits Stulp, Implement Consulting, says AI and global collaboration are key to addressing patent cliffs and accelerating ...

Managing a modern pharmaceutical supply chain is like building a house during a storm; it is no longer enough to ensure the ...

From a global regulatory perspective, Cytokinetics is expanding its footprint rapidly. The drug received approval in China on ...

Ultimately, these advancements suggest a more integrated ecosystem. Trusted regulatory spaces function like a communal ...